180 related articles for article (PubMed ID: 30815722)
1. Panobinostat, a histone deacetylase inhibitor, rescues the angiogenic potential of endothelial colony-forming cells in moyamoya disease.
Jangra A; Choi SA; Koh EJ; Moon YJ; Wang KC; Phi JH; Lee JY; Kim SK
Childs Nerv Syst; 2019 May; 35(5):823-831. PubMed ID: 30815722
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.
Lee JY; Moon YJ; Lee HO; Park AK; Choi SA; Wang KC; Han JW; Joung JG; Kang HS; Kim JE; Phi JH; Park WY; Kim SK
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1670-7. PubMed ID: 26023078
[TBL] [Abstract][Full Text] [Related]
3. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.
Choi SA; Chong S; Kwak PA; Moon YJ; Jangra A; Phi JH; Lee JY; Park SH; Kim SK
J Neurosurg Pediatr; 2018 Nov; 23(2):204-213. PubMed ID: 30668528
[TBL] [Abstract][Full Text] [Related]
4. Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.
Phi JH; Suzuki N; Moon YJ; Park AK; Wang KC; Lee JY; Choi SA; Chong S; Shirane R; Kim SK
PLoS One; 2017; 12(1):e0169714. PubMed ID: 28072843
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease.
Choi SA; Moon YJ; Koh EJ; Phi JH; Lee JY; Kim KH; Kim SK
J Korean Neurosurg Soc; 2023 Nov; 66(6):642-651. PubMed ID: 37138505
[TBL] [Abstract][Full Text] [Related]
6. The sulfated polysaccharide fucoidan rescues senescence of endothelial colony-forming cells for ischemic repair.
Lee JH; Lee SH; Choi SH; Asahara T; Kwon SM
Stem Cells; 2015 Jun; 33(6):1939-51. PubMed ID: 25693733
[TBL] [Abstract][Full Text] [Related]
7. Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease.
Kim JH; Jung JH; Phi JH; Kang HS; Kim JE; Chae JH; Kim SJ; Kim YH; Kim YY; Cho BK; Wang KC; Kim SK
J Neurosci Res; 2010 Feb; 88(3):510-8. PubMed ID: 19774676
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
[TBL] [Abstract][Full Text] [Related]
9. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity.
Poitevin S; Cussac D; Leroyer AS; Albinet V; Sarlon-Bartoli G; Guillet B; Hubert L; Andrieu-Abadie N; Couderc B; Parini A; Dignat-George F; Sabatier F
Cardiovasc Res; 2014 Jul; 103(1):121-30. PubMed ID: 24743591
[TBL] [Abstract][Full Text] [Related]
11. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells.
Heo SC; Kwon YW; Jang IH; Jeong GO; Yoon JW; Kim CD; Kwon SM; Bae YS; Kim JH
Stem Cells; 2014 Mar; 32(3):779-90. PubMed ID: 24155208
[TBL] [Abstract][Full Text] [Related]
12. Human endothelial colony forming cells from adult peripheral blood have enhanced sprouting angiogenic potential through up-regulating VEGFR2 signaling.
Joo HJ; Song S; Seo HR; Shin JH; Choi SC; Park JH; Yu CW; Hong SJ; Lim DS
Int J Cardiol; 2015 Oct; 197():33-43. PubMed ID: 26113473
[TBL] [Abstract][Full Text] [Related]
13. In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers.
Maschauer S; Gahr S; Gandesiri M; Tripal P; Schneider-Stock R; Kuwert T; Ocker M; Prante O
Nucl Med Biol; 2016 Jan; 43(1):27-34. PubMed ID: 26702784
[TBL] [Abstract][Full Text] [Related]
14. A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants.
Ligi I; Simoncini S; Tellier E; Vassallo PF; Sabatier F; Guillet B; Lamy E; Sarlon G; Quemener C; Bikfalvi A; Marcelli M; Pascal A; Dizier B; Simeoni U; Dignat-George F; Anfosso F
Blood; 2011 Aug; 118(6):1699-709. PubMed ID: 21659549
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.
Smadja DM; Bièche I; Silvestre JS; Germain S; Cornet A; Laurendeau I; Duong-Van-Huyen JP; Emmerich J; Vidaud M; Aiach M; Gaussem P
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2137-43. PubMed ID: 18818419
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation.
Harttrampf AC; da Costa MEM; Renoult A; Daudigeos-Dubus E; Geoerger B
BMC Cancer; 2021 Jul; 21(1):833. PubMed ID: 34281526
[TBL] [Abstract][Full Text] [Related]
17. Hybrid spheroids containing mesenchymal stem cells promote therapeutic angiogenesis by increasing engraftment of co-transplanted endothelial colony-forming cells in vivo.
Song YC; Park GT; Moon HJ; Choi EB; Lim MJ; Yoon JW; Lee N; Kwon SM; Lee BJ; Kim JH
Stem Cell Res Ther; 2023 Aug; 14(1):193. PubMed ID: 37533021
[TBL] [Abstract][Full Text] [Related]
18. Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential.
d'Audigier C; Gautier B; Yon A; Alili JM; Guérin CL; Evrard SM; Godier A; Haviari S; Reille-Serroussi M; Huguenot F; Dizier B; Inguimbert N; Borgel D; Bièche I; Boisson-Vidal C; Roncal C; Carmeliet P; Vidal M; Gaussem P; Smadja DM
Angiogenesis; 2014 Jul; 17(3):603-16. PubMed ID: 24419917
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.
Jung KH; Chu K; Lee ST; Park HK; Kim DH; Kim JH; Bahn JJ; Song EC; Kim M; Lee SK; Roh JK
J Cereb Blood Flow Metab; 2008 Nov; 28(11):1795-803. PubMed ID: 18612318
[TBL] [Abstract][Full Text] [Related]
20. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
